Skip to content
Screener

Clover Health Investments CLOV Q1 2025 earnings

Reported May 6, 2025 · After market close

Revenue$462.3MMiss by $4.6M
EPS$0.05Beat by $0.12
Revenue estimate$466.9M
EPS estimate-$0.07

Next report

Nov 3, 2026 (in 2 months)
Revenue estimate$740.3M
EPS estimate-$0.01

Financials

Q1 2025

Income statement

See full
Revenue$462.3M+33.3%
Operating income-$1.3M+94.4%
Net income-$1.3M+93.4%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$155.4M-25.4%
Total equity$336.1M+14.9%
Total assets$583.7M-13.1%

Cash flow

See full
Operating cash flow-$16.3M-163%
CapEx$185.0K-58.4%
Free cash flow-$16.5M-165%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$1.83B+375%
P/S1.2×+0.9×

Profitability

See full
Operating margin-1.6%-0.8pp
Net margin-1.7%-0.8pp

Returns & leverage

See full
Return on equity-8%-3.7pp
Current ratio1.5×0.0×

FAQ

When did Clover Health Investments report Q1 2025 earnings?
Clover Health Investments (CLOV) reported Q1 2025 earnings on May 6, 2025 after market close.
What were Clover Health Investments's Q1 2025 revenue and EPS?
Clover Health Investments reported revenue of $462.3M and eps of $0.05 for Q1 2025.
Did Clover Health Investments beat estimates in Q1 2025?
Revenue missed the consensus estimate of $466.9M by $4.6M. EPS beat the consensus estimate of $-0.07 by $0.12.
How did Clover Health Investments's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 33.3% from $346.9M a year earlier.
Where can I find Clover Health Investments's Q1 2025 SEC filings?
You can read the 8-K earnings release (0001801170-25-000127) and the 10-Q periodic report (0001801170-25-000132) directly on SEC EDGAR. The filing index links above go to sec.gov.